Front & Back Matter.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 1, doi. 10.1159/000519092
- Publication type:
- Article
Works matching IS 00093157 AND DT 2021 AND VI 66 AND IP 3
Results: 10
1
2
Two Novel Mutations Associated with Polymyxin-B Resistance in a Pandemic Lineage of Uropathogenic Escherichia coli of the Sequence Type 69.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 92, doi. 10.1159/000517817
- By:
- Publication type:
- Article
3
Successful Treatment of a Locally Recurrent and Metastatic Malignant Phyllodes Tumor with Accelerated Radiotherapy and Nab-Paclitaxel, Cisplatin, and Liposomal Doxorubicin Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 82, doi. 10.1159/000517246
- By:
- Publication type:
- Article
4
Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy following FOLFIRINOX in Patients with Unresectable Pancreatic Cancer: A Single-Institution, Retrospective Analysis.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 58, doi. 10.1159/000517244
- By:
- Publication type:
- Article
5
Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatinib.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 78, doi. 10.1159/000516593
- By:
- Publication type:
- Article
6
Safety and Survival Outcomes in Lung Cancer Patients Receiving Carboplatin: Impact of Uncapped Dosage.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 72, doi. 10.1159/000516170
- By:
- Publication type:
- Article
7
Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 53, doi. 10.1159/000515748
- By:
- Publication type:
- Article
8
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 87, doi. 10.1159/000515430
- By:
- Publication type:
- Article
9
Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 99, doi. 10.1159/000515100
- By:
- Publication type:
- Article
10
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 3, p. 65, doi. 10.1159/000514841
- By:
- Publication type:
- Article